Promethium Advisors »

iShares Dow Jones US Medical Dev. shares owned by Promethium Advisors

Quarter-by-quarter ownership of iShares Dow Jones US Medical Dev. (IHI) shares owned by Promethium Advisors from 13F filings

Historical chart of Promethium Advisors investment in iShares Dow Jones US Medical Dev.

Tip: Access up to 7 years of quarterly data

All positions including iShares Dow Jones US Medical Dev. held by Promethium Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in iShares Dow Jones US Medical Dev. by Promethium Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $525k 8.9k 59.22

More positions owned by Promethium Advisors

Apple (AAPL)
Thomson Reuters Corp. (TRI)
Pfizer (PFE)
Bristol Myers Squibb (BMY)
Broadstone Net Lease (BNL)
T. Rowe Price (TROW)
Texas Pacific Land Corp (TPL)
Alphabet Cap Stk Cl A (GOOGL)
Danaher Corporation (DHR)
Alphabet Cap Stk Cl C (GOOG)
Abbvie (ABBV)
Cme (CME)
Ishares Tr U.s. Tech Etf (IYW)
Johnson & Johnson (JNJ)
Spdr Ser Tr Bloomberg 3-12 M (BILS)

View all positions for Promethium Advisors

Top funds holding iShares Dow Jones US Medical Dev.

Citigroup
Morgan Stanley
Bank of America Corporation
LPL Financial
Fisher Investments
Jpmorgan Chase & Co
Wells Fargo & Company
Envestnet Asset Management
Royal Bank of Canada
International Assets Investment Management
Point72 Asset Management
Goldman Sachs Group
Raymond James & Associates
Commonwealth Equity Services
RiverFront Investment Group

View all funds holding iShares Dow Jones US Medical Dev.